CN1265152A - 通过同源重组在人细胞中生产人突变蛋白 - Google Patents

通过同源重组在人细胞中生产人突变蛋白 Download PDF

Info

Publication number
CN1265152A
CN1265152A CN98807438A CN98807438A CN1265152A CN 1265152 A CN1265152 A CN 1265152A CN 98807438 A CN98807438 A CN 98807438A CN 98807438 A CN98807438 A CN 98807438A CN 1265152 A CN1265152 A CN 1265152A
Authority
CN
China
Prior art keywords
nucleic acid
cell
sequence
homologous recombination
target nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98807438A
Other languages
English (en)
Chinese (zh)
Inventor
A·斯特恩
K·霍诺德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1265152(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Priority to CN200810130044.0A priority Critical patent/CN101348789B/zh
Publication of CN1265152A publication Critical patent/CN1265152A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
CN98807438A 1997-07-23 1998-07-22 通过同源重组在人细胞中生产人突变蛋白 Pending CN1265152A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810130044.0A CN101348789B (zh) 1997-07-23 1998-07-22 通过同源重组在人细胞中生产人突变蛋白

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97112639 1997-07-23
EP97112639.6 1997-07-23

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN200810130044.0A Division CN101348789B (zh) 1997-07-23 1998-07-22 通过同源重组在人细胞中生产人突变蛋白

Publications (1)

Publication Number Publication Date
CN1265152A true CN1265152A (zh) 2000-08-30

Family

ID=8227102

Family Applications (2)

Application Number Title Priority Date Filing Date
CN200810130044.0A Expired - Lifetime CN101348789B (zh) 1997-07-23 1998-07-22 通过同源重组在人细胞中生产人突变蛋白
CN98807438A Pending CN1265152A (zh) 1997-07-23 1998-07-22 通过同源重组在人细胞中生产人突变蛋白

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN200810130044.0A Expired - Lifetime CN101348789B (zh) 1997-07-23 1998-07-22 通过同源重组在人细胞中生产人突变蛋白

Country Status (17)

Country Link
US (2) US6444441B1 (enExample)
EP (1) EP1000167B2 (enExample)
JP (1) JP2001511341A (enExample)
KR (1) KR100512018B1 (enExample)
CN (2) CN101348789B (enExample)
AR (2) AR013251A1 (enExample)
AT (1) ATE313643T1 (enExample)
AU (1) AU729489B2 (enExample)
BR (1) BR9811531A (enExample)
CA (1) CA2297660C (enExample)
DE (1) DE59813296D1 (enExample)
DK (1) DK1000167T4 (enExample)
ES (1) ES2255177T5 (enExample)
PT (1) PT1000167E (enExample)
TR (1) TR200000172T2 (enExample)
WO (1) WO1999005264A2 (enExample)
ZA (1) ZA986517B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102789754B1 (ko) * 2016-01-06 2025-03-31 론자 리미티드 개선된 생산을 위한 단백질 분해의 억제

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234686A (en) * 1985-04-03 1993-08-10 Beecham Group P.L.C. Human tissue plasminogen activator consisting essentially of t-PA residues to 160 to 527, pharmaceutical compositions and methods of treatment
US5094953A (en) * 1988-03-21 1992-03-10 Genentech, Inc. Human tissue plasminogen activator variants
DE3903581A1 (de) * 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh Gewebs-plasminogenaktivator-derivat
DE3907679A1 (de) * 1989-03-09 1990-09-13 Max Planck Gesellschaft Verfahren zur gezielten veraenderung eines gens
JPH0576361A (ja) * 1990-05-10 1993-03-30 Takeda Chem Ind Ltd 組織プラスミノーゲンアクチベータームテイン
US5612205A (en) 1990-08-29 1997-03-18 Genpharm International, Incorporated Homologous recombination in mammalian cells
WO1992020808A1 (en) * 1991-05-15 1992-11-26 Cell Genesys, Inc. Genomic modifications with homologous dna targeting
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6270989B1 (en) * 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
DE69333955D1 (de) * 1992-04-24 2006-02-02 Stanford Res Inst Int Targeting homologer sequenzen in eukaryotenzellen
WO1994004032A1 (en) * 1992-08-21 1994-03-03 The Regents Of The University Of California Composition and method for altering dna sequences by homologous recombination
TW402639B (en) * 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
CN1256986C (zh) * 1993-12-02 2006-05-24 转移染色体治疗公司 蛋白质的生产和蛋白质的输送
AU6328696A (en) * 1995-06-07 1996-12-30 Yale University Treatment of hemoglobinopathies
US6087129A (en) * 1996-01-19 2000-07-11 Betagene, Inc. Recombinant expression of proteins from secretory cell lines

Also Published As

Publication number Publication date
AU9067398A (en) 1999-02-16
AR013251A1 (es) 2000-12-13
US20020068318A1 (en) 2002-06-06
ATE313643T1 (de) 2006-01-15
EP1000167B1 (de) 2005-12-21
BR9811531A (pt) 2000-08-22
DK1000167T3 (da) 2006-04-24
PT1000167E (pt) 2006-05-31
DE59813296D1 (de) 2006-01-26
CN101348789B (zh) 2016-08-17
ES2255177T3 (es) 2006-06-16
US6444441B1 (en) 2002-09-03
EP1000167A2 (de) 2000-05-17
EP1000167B2 (de) 2011-04-20
WO1999005264A2 (de) 1999-02-04
CN101348789A (zh) 2009-01-21
TR200000172T2 (tr) 2000-12-21
KR100512018B1 (ko) 2005-09-02
CA2297660C (en) 2010-04-27
ES2255177T5 (es) 2011-07-12
KR20010022127A (ko) 2001-03-15
US20020177195A1 (en) 2002-11-28
ZA986517B (en) 2000-01-24
AR068104A2 (es) 2009-11-04
AU729489B2 (en) 2001-02-01
CA2297660A1 (en) 1999-02-04
JP2001511341A (ja) 2001-08-14
WO1999005264A3 (de) 1999-04-22
DK1000167T4 (da) 2011-08-08

Similar Documents

Publication Publication Date Title
AU629176B2 (en) Recombinant fibroblast growth factors
CN112724259B (zh) 人血清白蛋白与白介素2的融合蛋白及其用途
US20100120089A1 (en) A novel vector and expression cell line for mass production of recombinant protein and a process of producing recombinant protein using same
JPH09501309A (ja) アデノ関連性ウイルスレプタンパク質および細菌性タンパク質含有融合タンパク質
JP3121611B2 (ja) 神経成長因子を真核生物細胞において発現させるための遺伝子ベクター
HUT56134A (en) Process for producing and purifying recombinant human interleukin-3 and its muteins
JP6861637B2 (ja) グロビン遺伝子クラスターの制御エレメントを含む真核性の発現ベクター
WO2020187268A1 (zh) 一种增强基因编辑的融合蛋白及其应用
JPH0463595A (ja) ヒトインターロイキン３誘導体
CN1265152A (zh) 通过同源重组在人细胞中生产人突变蛋白
MXPA00000645A (es) Produccion de proteinas mutadas humanas en celulas humanas por medio de recombinacion homologa
WO2024245139A1 (en) Gene editing systems and uses thereof
CN120554490B (zh) 一种重组iv型人源化胶原蛋白及其纯化工艺
KR102008407B1 (ko) 코돈 최적화된 il-21 및 이의 용도
JPH0638773A (ja) 薬剤耐性構造タンパク質遺伝子を選択遺伝子として用いた発現ベクター
WO2023210607A1 (ja) Ｅｎｏ１遺伝子のプロモーター
KR101402272B1 (ko) 신규한 ｇ-ｃｓｆ 폴리뉴클레오티드 및 이의 용도
KR20250167670A (ko) 초극소 역위 말단 반복(itr) 서열 및 그의 용도
KR20120057416A (ko) 인간 ｇ－ｃｓｆ 단백질 생산을 위한 폴리뉴클레오티드 및 이의 용도
CN115232215A (zh) 一种融合蛋白ABD/Fc/IL-2及其编码基因、制备方法和应用
JPH0482900A (ja) 新規ｍ―ｃｓｆ及びその製造方法
WO1993001214A1 (fr) Interleukine 6 humaine de recombinaison avec terminaison n homogene et production de cette interleukine
JPS63164898A (ja) 新規生理活性ポリペプチド
EP2912173A1 (en) Process for preparation and purification of recombinant human oncostatin m protein
JPS61199786A (ja) ウサギインタ−ロイキン１をコ−ドする新規ｄｎａ

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication